ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

ROLES OF FAMILY DOCTORS IN SCREENING FOR FATTY LIVER DISEASE

Sultan Thayer N Alharbi, Abdulelah Mohammed Alruwaili, Adel Ateyyah K Aldhafiri

To estimate the screening and diagnostic methods of fatty liver in patients in a primary care setting. Detailed computerized search of literature was performed through several medical databases; Midline/PubMed, Science direct, and Emabse, search was conducted to find relevant studies discussing the screening for fatty liver disease in primary careBy primary physicians there should be a high index of suspicion for NAFLD and NASH in patients with type 2 diabetes. Clinical decision help such as NAFLD Fibrosis Score or FIB4 or vibration controlled transient elastography (VCTE) could be used to identify those at low or high risk for advanced fibrosis (connecting fibrosis or cirrhosis). Education and understanding are very essential. They need to target primary care doctors because they have a better connection with patients than our team showing up and offering the FibroScan.However Routine Screening for NAFLD in high-risk groups participating in primary care, diabetes, or obesity clinics is not advised at this time as a result of unpredictabilities surrounding diagnostic tests and treatment options, together with absence of knowledge pertaining to long-term advantages and costeffectiveness of screening.

FULL TEXT